Published in J Epidemiol Community Health on February 01, 2000
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37
Places, people, and their physical and mental functional health. J Epidemiol Community Health (2004) 1.28
Healthy lifestyle choices: could sense of coherence aid health promotion? J Epidemiol Community Health (2007) 1.02
Socioeconomic status, financial hardship and measured obesity in older adults: a cross-sectional study of the EPIC-Norfolk cohort. BMC Public Health (2013) 0.88
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry (1981) 18.92
Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry (1978) 15.32
Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ (1993) 14.37
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry (1988) 12.83
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry (1990) 8.52
Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Arch Gen Psychiatry (1998) 8.29
Cross-national epidemiology of major depression and bipolar disorder. JAMA (1996) 7.98
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst (1998) 4.27
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
Depression and the course of coronary artery disease. Am J Psychiatry (1998) 3.17
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care (1996) 2.78
The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. Psychol Med (1997) 2.74
A comparison of clinical and diagnostic interview schedule diagnoses. Physician reexamination of lay-interviewed cases in the general population. Arch Gen Psychiatry (1985) 2.66
Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet (1995) 2.57
Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol (1996) 2.48
Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ (1998) 2.38
Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation (1996) 2.27
Association of depression with 10-year poststroke mortality. Am J Psychiatry (1993) 2.26
Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA (1989) 2.16
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Depression in women: implications for health care research. Science (1995) 1.98
Deriving a survey measure of social support: the reliability and validity of the Close Persons Questionnaire. Soc Sci Med (1992) 1.92
The lifetime history of major depression in women. Reliability of diagnosis and heritability. Arch Gen Psychiatry (1993) 1.87
Is the lifetime risk of depression actually increasing? J Clin Epidemiol (1995) 1.83
Affective disorders in five United States communities. Psychol Med (1988) 1.78
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity . Psychol Med (1998) 1.67
Depressed mood and development of cancer. Am J Epidemiol (1990) 1.66
Reevaluation of secular trends in depression rates. Am J Epidemiol (1992) 1.66
Epidemiology: reflections on testing the validity of psychiatric interviews. Arch Gen Psychiatry (1985) 1.65
Coronary heart disease: a review of the role of psychosocial stress and social support. J Public Health Med (1996) 1.59
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav Med (1990) 1.43
Measuring health status with the SF-36: the need for regional norms. J Public Health Med (1995) 1.31
Sex and depression. Psychol Med (1998) 1.24
Premorbid psychological factors as related to cancer incidence. J Behav Med (1978) 1.17
Psychological depression and 17-year risk of death from cancer. Psychosom Med (1981) 1.15
Stability of psychiatric diagnoses. An application to the affective disorders. Arch Gen Psychiatry (1992) 1.09
Psychopathology and mortality in the general population. Soc Psychiatry Psychiatr Epidemiol (1995) 1.07
The role of psychological factors in cancer incidence and prognosis. Oncology (Williston Park) (1995) 1.07
Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study. J Behav Med (1988) 1.06
Psychosocial influences on cancer incidence and progression. Harv Rev Psychiatry (1998) 1.01
Increased rates of depression: update of epidemiological findings and analytical problems. Acta Psychiatr Scand (1994) 0.98
Dietary assessments in the European prospective study of diet and cancer (EPIC). Eur J Cancer Prev (1997) 0.93
'The problem of validity in field studies of psychological disorders' revisited. Psychol Med (1990) 0.91
Are the lifetime prevalence estimates in the ECA study accurate? Psychol Med (1987) 0.90
A psychosocial perspective on the past and future of psychiatric epidemiology. Am J Epidemiol (1998) 0.87
Follow up study of longstanding depression as predictor of mortality in elderly people living in the community. BMJ (1999) 0.84
Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. Am J Public Health (1999) 0.83
Diagnostic boundaries, reasoning and depressive disorder, I. Development of a probabilistic morbidity model for public health psychiatry. Psychol Med (1997) 0.81
Depression, smoking, and lung cancer. Am J Epidemiol (1996) 0.78
Misuse of psychiatric epidemiology. Lancet (1998) 0.76
Diagnostic boundaries, reasoning and depressive disorder, II. Application of a probabilistic model to the OPCS general population survey of psychiatric morbidity in Great Britain. Psychol Med (1997) 0.76
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
The prevalence of frontotemporal dementia. Neurology (2002) 5.73
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Dementia and survival in Parkinson disease: a 12-year population study. Neurology (2008) 1.86
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology (2008) 1.76
Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry (1994) 1.66
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population. Br J Psychiatry (2001) 1.62
The impact on prevalence of dementia in the oldest age groups of differential mortality patterns: a deterministic approach. Int J Epidemiol (1998) 1.62
CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol (1995) 1.62
Exploring the impact of prevalence and mortality on incidence of dementia in the oldest old: the sensitivity of a deterministic approach. Neuroepidemiology (2001) 1.60
A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand (2006) 1.49
Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol (2001) 1.48
Increased fructose intake as a risk factor for dementia. J Gerontol A Biol Sci Med Sci (2010) 1.48
In the shadow of adversity: the evolution and resolution of anxiety and depressive disorder. Br J Psychiatry (1995) 1.45
Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain (2009) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Profile of disability in elderly people: estimates from a longitudinal population study. BMJ (1999) 1.38
Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging (2008) 1.35
Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology (2000) 1.35
Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology (2008) 1.32
Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort. J Epidemiol Community Health (1999) 1.30
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol (2000) 1.28
Factors associated with functional decline and improvement in a very elderly community-dwelling population. Am J Epidemiol (1999) 1.22
Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil (1997) 1.19
Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci (2000) 1.17
White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol (2007) 1.14
Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obes Rev (2011) 1.12
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
The ACE gene and Alzheimer's disease susceptibility. J Med Genet (2000) 1.11
Determinants of general practitioner recognition of psychological problems in a multi-ethnic inner-city health district. Br J Psychiatry (1997) 1.09
The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08
Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population. Psychol Med (2001) 1.08
Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp Gerontol (1998) 1.07
Cognitive function in the Caerphilly study: associations with age social class, education and mood. Eur J Epidemiol (1999) 1.05
Incidence of functional decline and improvement in a community-dwelling, very elderly population. Am J Epidemiol (1997) 1.05
Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.04
Cognitive impairment in elderly people: population based estimate of the future in England, Scotland, and Wales. BMJ (1997) 1.04
Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG. Int J Geriatr Psychiatry (2000) 1.03
Prospective association between emotional health and clinical evidence of Parkinson's disease. Eur J Neurol (2008) 1.03
The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol Psychiatry (2011) 1.02
Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology (2000) 1.01
Socioeconomic status and the expectation of disability in old age: estimates for England. J Epidemiol Community Health (2000) 1.01
Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J Med Genet (2002) 1.00
Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol (2007) 1.00
Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol (2009) 1.00
Changes in self-rated health, disability and contact with services in a very elderly cohort: a 6-year follow-up study. Age Ageing (1998) 0.99
Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2007) 0.98
The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. Ann Neurol (1991) 0.98
A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD). Neurobiol Aging (2009) 0.94
Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (1998) 0.94
Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J Am Geriatr Soc (2001) 0.94
Prevalence and symptomatology of depression in older people living in institutions in England and Wales. Age Ageing (2007) 0.93
Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol (2014) 0.93
Co-occurrence of anxiety and depression amongst older adults in low- and middle-income countries: findings from the 10/66 study. Psychol Med (2011) 0.93
Epidemiology of vascular dementia. Neuroepidemiology (1995) 0.92
Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am J Epidemiol (2000) 0.92
Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery. Int J Geriatr Psychiatry (2001) 0.90
The role of life events and childhood experiences in the development of rheumatoid arthritis. J Rheumatol (2000) 0.90
The prevalence of depression in a cohort of the very elderly. J Affect Disord (1995) 0.89
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. J Intern Med (2014) 0.88
Incidence of dementia and cognitive decline in over-75s in Cambridge: overview of cohort study. Soc Psychiatry Psychiatr Epidemiol (1998) 0.88
Surviving adversity: event decay, vulnerability and the onset of anxiety and depressive disorder. Eur Arch Psychiatry Clin Neurosci (1999) 0.88
The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport (2001) 0.88
Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement Geriatr Cogn Disord (2009) 0.87
Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Disord (2001) 0.87
Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiol Aging (1995) 0.86
Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort. Int J Obes (Lond) (2010) 0.86
Estimation of verbal intelligence in an elderly community: a prediction analysis using a shortened NART. Br J Clin Psychol (1990) 0.86
Screening for dementia--is it a no brainer? Int J Clin Pract (2013) 0.86
Smoking and the brain. BMJ (2000) 0.86
Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dement Geriatr Cogn Disord (2008) 0.85
Epidemiologic approach to the study of dementing diseases: a nested case-control study in European incidence studies of dementia. Neuroepidemiology (1992) 0.85
Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort. Dement Geriatr Cogn Disord (2012) 0.85
Research and Alzheimer's disease: an epidemiological perspective. Psychol Med (1993) 0.84
Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol (2013) 0.84
Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol Appl Neurobiol (2011) 0.84
An investigation of ACE as a risk factor for dementia and cognitive decline in the general population. J Med Genet (2002) 0.84
Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging (1995) 0.84
Future imperfect: the long-term outcome of depression. Br J Psychiatry (1994) 0.84
The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years. J Med Genet (1996) 0.84
The genetic basis of Parkinson's disease. J Neurol Neurosurg Psychiatry (2002) 0.84
Biomarkers, dementia, and public health. Ann N Y Acad Sci (2009) 0.84
Depression in the elderly: pathological study of raphe and locus ceruleus. Neuropathol Appl Neurobiol (2005) 0.83
Suicidal thinking in community residents over eighty. Int J Geriatr Psychiatry (1997) 0.83
Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet (2001) 0.83
Is Alzheimer's disease distinct from normal ageing? Lancet (1988) 0.82
Longitudinal studies of ageing: a key role in the evidence base for improving health and quality of life in older adults. Age Ageing (2000) 0.81
Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype. Neuropathol Appl Neurobiol (2011) 0.81
Fragile states of mind: neuroticism, vulnerability and the long-term outcome of depression. Br J Psychiatry (1996) 0.80
Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes. Am J Med Genet (2001) 0.80
Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework. J Nutr Health Aging (2015) 0.80
The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci (1996) 0.80
Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol Appl Neurobiol (2007) 0.79
The association between social stress and global cognitive function in a population-based study: the European Prospective Investigation into Cancer (EPIC)-Norfolk study. Psychol Med (2012) 0.78
Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease. Neurosci Lett (2009) 0.78